The pathology of REM sleep behavior disorder with lewy body dementia: More than co-incidence

2000 ◽  
Vol 21 ◽  
pp. 16
Author(s):  
R. Scott Turner ◽  
Ronald D. Chervin
Neurology ◽  
2000 ◽  
Vol 55 (11) ◽  
pp. 1730-1732 ◽  
Author(s):  
R. S. Turner ◽  
C. J. D'Amato ◽  
R. D. Chervin ◽  
M. Blaivas

SLEEP ◽  
2017 ◽  
Vol 40 (2) ◽  
Author(s):  
Taeko Sasai-Sakuma ◽  
Yoshiyuki Nishio ◽  
Kayoko Yokoi ◽  
Etsuro Mori ◽  
Yuichi Inoue

2017 ◽  
Vol 37 (04) ◽  
pp. 461-470 ◽  
Author(s):  
Verna Porter ◽  
Alon Avidan

AbstractRapid eye movement (REM) sleep behavior disorder (RBD) is a parasomnia characterized by loss of muscle atonia during REM sleep that allows motor responses to dream content. Patients display patterns of unusual, complex, and even violent motor activities. There is a high risk for harm to the patients or their bedpartners. REM sleep behavior disorder is more likely to occur in synucleinopathies such as Parkinson's disease, Lewy body dementia, and multiple system atrophy and may precede clinical manifestations by decades. In secondary RBD, brainstem centers involved in muscle atonia during REM are disrupted. These conditions include multiple sclerosis, cerebral vascular accidents, and brainstem tumors. The acute onset of RBD may associate with the use of antidepressants and acute withdrawal from alcohol. The diagnosis of RBD should be confirmed by polysomnography utilizing multiple-limb electromyography and synchronized digital video monitoring and demonstrate elevation of muscle tone during REM sleep along with dream enactment behavior. The differential diagnosis includes sleepwalking, nocturnal seizures, sleep apnea, and periodic limb movement disorder. Management focuses on maximizing safety, use of clonazepam/melatonin, and discussion of prognosis with patients.


Neurology ◽  
1995 ◽  
Vol 45 (4) ◽  
pp. 709-712 ◽  
Author(s):  
M. Uchiyama ◽  
K. Isse ◽  
K. Tanaka ◽  
N. Yokota ◽  
M. Hamamoto ◽  
...  

2011 ◽  
Vol 2011 ◽  
pp. 1-8 ◽  
Author(s):  
Tomoyuki Miyamoto ◽  
Masayuki Miyamoto ◽  
Masaoki Iwanami ◽  
Koichi Hirata

Objectives. Both results of the odor identification and cardiac123I-metaiodobenzylguanidine accumulation have been investigated for their potential to enhance the detection of pathogenesis resembling that of Lewy body-relatedα-synucleinopathies in patients clinically diagnosed as having idiopathic REM sleep behavior disorder.Methods. We performed both the Odor Stick Identification Test for Japanese and123I-metaiodobenzylguanidine scintigraphy in 30 patients with idiopathic REM sleep behavior disorder, 38 patients with Parkinson's disease, and 20 control subjects.Results. In idiopathic REM sleep behavior disorder, reduced odor identification score and an early or delayed heart to mediastinum ratio on123I-metaiodobenzylguanidine were almost as severe as in Parkinson's disease patients. Delayed cardiac123I-metaiodobenzylguanidine uptake was even more severe in the idiopathic REM sleep behavior disorder group than in the Parkinson's disease group.Conclusions. Reduced cardiac123I-metaiodobenzylguanidine uptake, which is independent of parkinsonism, may be more closely associated with idiopathic REM sleep behavior disorder than olfactory impairment.


Neurology ◽  
1997 ◽  
Vol 49 (2) ◽  
pp. 523-527 ◽  
Author(s):  
R. S. Turner ◽  
R. D. Chervin ◽  
K. A. Frey ◽  
S. Minoshima ◽  
D. E. Kuhl

Sign in / Sign up

Export Citation Format

Share Document